|
|
Research on Primary HIV Infection
- Unique, Statewide Program of Acute HIV Testing and Partner Outreach Finds That Many Acute Infections in North Carolina May Stem From Exposure to Chronically Infected Patients (February 5, 2008)
An Interview With Sandra McCoy, Ph.D.
From The Body PRO
- HIV Viral Load in Semen Is Highest Three to Four Weeks After Infection, Study Says (August 28, 2007)
From aidsmap.com
- Three Months of Meds in Early Infection May Slow Down HIV in the Long Run (June 26, 2007)
From aidsmap.com
- An Overview of the Pathogenesis and Treatment of Primary HIV Infection (September 28, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
- Does Early Treatment of Primary HIV Infection Delay Treatment Indication? (August 14, 2006)
In XVI International AIDS Conference
- Seroreversion in Subjects Receiving Antiretroviral Therapy During Acute/Early HIV Infection (PDF) (March 1, 2006)
In Clinical Infectious Diseases
- Detecting Primary HIV Infection: Important for Prevention and, Extremely Rarely, Treatment as Well (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
- HIV JournalView: A Novel -- and Essential -- Method for Spotting Acute HIV Infections (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO
- HIV JournalView: Reducing Latent HIV Reservoirs (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO
- HIV Transmission Highest During Acute Infection and End-Stage Disease (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO
- Acute HIV Infection: A Unique Opportunity to Intervene (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- HAART During Acute Infection Does Not Confer Long-Term Virologic Benefit, Study Suggests (November 2004)
Full text of a study by Bruce Walker, M.D., and colleagues.
In PLoS Medicine
- HIV JournalView: Primary Drug Resistance Can Persist a Year or More (September 2004)
From The Body PRO
- Negative HIV Antibody Test Results Among People Treated During Acute/Early Infection (July 12, 2004)
In The XV International AIDS Conference, from The Body PRO
- Rapid Clearance of HIV After Acute Infection Linked to Lower Risk of Disease Progression (May 11, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Little Benefit Seen for Treatment During Acute Infection (February 9, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Losing Control: Breakthroughs in Bruce Walker's Acute Infection Cohort (May 2003)
In TAGline, from Treatment Action Group
- High Replication Capacity Is Associated With High Baseline Viral Load in Untreated Subjects With Primary HIV Infection (February 13, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Is HAART for Primary/Early HIV Infection Associated With Improved Outcomes After Treatment Discontinuation? (February 13, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- The QUEST Cohort: Treatment of Primary HIV Infection With Quadruple HAART: Week 48 Preliminary Results (February 13, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Antiretroviral Resistance Among Patients With Primary HIV Infection in the Southeastern U.S. -- Impact on Treatment Outcome (February 11, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Primary HIV-1 Infection in African Children Infected Through Breastfeeding (December 30, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New University of North Carolina Study Reveals Screening Tests Can Boost Early Discovery of AIDS Virus (August 13, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Antiretroviral-Drug Resistance Among Patients Recently Infected With HIV (August 8, 2002)
Greater primary resistance necessitates earlier drug-resistance testing, researchers say.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Is Simplification to Triple Antiretroviral Therapy After Viral Suppression With Quadruple Therapy Initiated at the Time of Primary Infection Associated With Increased Low-Level Viral Breakthrough? (July 11, 2002)
In The XIV International AIDS Conference, from The Body PRO
- A Synergistic Effect of HIV and CMV Infection/Reactivation on Response to HAART and Plasma CD8+/CD38+ But Not CD4+ Cell Populations in Patients With Primary HIV Infection (July 10, 2002)
In The XIV International AIDS Conference, from The Body PRO
- When to Start Antiretroviral Therapy? (February 26, 2002)
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Can Treatment During Primary HIV Infection Lead to Control of Disease Without Drugs? (Winter 2002)
In Research Initiative/Treatment Action!, from The Center for AIDS
- HIV Highly Contagious Before Symptoms Show (January/February 2002)
In Body Positive, from Body Positive
- Primary HIV Infection Case Presentations (Winter 2002)
In Research Initiative/Treatment Action!, from The Center for AIDS
- The Acute Infection and Early Disease Research Program (Winter 2002)
In Research Initiative/Treatment Action!, from The Center for AIDS
- Structured Treatment Interruptions (STI) in Patients Receiving HAART Since Primary HIV-1 Infection (PHI): Spontaneous Control of Viremia in Almost Half of Cases After the First Two Cycles Off Therapy (December 18, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
- Greater Suppression of CD8 Activation with Four vs. Three Drugs in Early Stages of Primary HIV Infection (PHI) Despite Similar Plasma Virological Decay Rates (July 10, 2001)
In The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- A Randomized Trial of Interleukin-2 (IL-2) Added to HAART for Primary HIV (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Clinical Features of Acute Retroviral Syndrome (ARS) by Gender and Age (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- The Effect of Pre-Treatment on Success of HAART Among Patients With Primary HIV (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Thymic Reconstitution in Primary HIV Infection (PHI) Following HAART Is Polyclonal (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Recent Issues in Primary HIV: From Diagnosis to Oral Sex Transmission (November 7, 2000)
In The PRN Notebook
- Primary Infection (Spring 1996)
In STEP Perspective, from Seattle Treatment Education Project
|
|
